ๆญฏ๊ธฐ๋Šฅ์„ฑ์‹ํ’ˆํŠนํ—ˆ๋ถ„์„3.PDF



Similar documents
รร–ยบรŽ10ยบยปยนยฎ-รƒร–รยพ

untitled

ยบรฑยธยธ1ร€รฅ

untitled

Act84_

6ร€รฅยตยถยผยบยฟยฌยฑยธยบรยพรŸ

็ฌฌ 1 ็ฏ€ ็ต„ ็น” 11 ็ฌฌ 1 ็ซ  ๆชข ๅฏŸ ์˜ ็ต„ ็น” ไบบ ไบ‹ ๅˆถ ๅบฆ ๋“ฑ ็ฌฌ 1 ้ … ๅคง ๆชข ๅฏŸ ๅปณ ็ฌฌ 1 ็ฏ€ ็ต„ ๋Œ€๊ฒ€์ฐฐ์ฒญ์€ ๋Œ€๋ฒ•์›์— ๋Œ€์‘ํ•˜์—ฌ ์ˆ˜๋„์ธ ์„œ์šธ์— ์œ„์น˜ ํ•œ๋‹ค(๊ฒ€์ฐฐ์ฒญ๋ฒ• ์ œ2์กฐ,์ œ3์กฐ,๋Œ€๊ฒ€์ฐฐ์ฒญ์˜ ์œ„์น˜์™€ ๊ฐ๊ธ‰ ๊ฒ€์ฐฐ์ฒญ์˜๋ช…์นญ๋ฐ์œ„์น˜์—๊ด€ํ•œ๊ทœ์ • ์ œ2์กฐ). ๋Œ€๊ฒ€์ฐฐ์ฒญ์— ๊ฒ€์ฐฐ์ด์žฅ,๋Œ€

8ยบยปยนยฎ-รƒร–รยพ-ยผรถรยค

#ยณรณรƒรŒยฐรฆรยฆ 64รˆยฃ-ร„ยฎยถรณยธรฉ

ยพรˆยตยฟยฑยณรˆยธยบยธรƒร–รยพ

ยพร‹ยฑรขยฝยฌยฟรฎร€ยฑยธยฎยฐรฆยฟยตc03ร–รยพลก


Today4-5์›”-0326

04-ร†ยฏรรฝ2b71รšยฐรฆยฝร„ลก

untitled

untitled

ยฝร…ยณรขรˆยฃ-ร‡ยฅรรถ

<30322E20B9ABBCB1B7A32E687770>

untitled

<322E20BEC6BDC3BEC62D32C2F728BCF6C1A4292E687770>

Patent21(51..)....

์„œ๋ก  34 2

์ „์ฒด ๋ชฉ์ฐจ 1. ์ฃผ๋ฅ˜ ์ผ๋ฐ˜ 2. ๊ธฐ๋Šฅ์„ฑ 3. ์ˆ™์ทจ 4. ์ฃผ์„ธ๋ฒ• 5. ์ฃผ๋ฅ˜ ์ผ๋ฐ˜ ์ƒ์‹ 6. ์šฐ๋ฆฌ์ˆ  ์ฆ๊ธฐ๊ธฐ

๋ ˆ์ด์•„์›ƒ 1

NV9_Ver1.2

<B1B9BEEEBEEEC8D6B7C25FB9AEB9FDBEEEC8D E687770>

ๆญฏ111

<5BC6EDC1FD5D20BFA9BCBAC0CEC0E7C8B0BFEBB0FA20BEE7BCBAC6F2B5EE20BDC7C3B BDC7C3B5B0FAC1A6BAB020BCB3B8EDC0DAB7E12E687770>

Microsoft Word valuation_Korean.doc

ยฟร€ยธยฎร„รž40

YISO Wireless Co., Ltd 2/68 Proprietary & Confidential

9ยฟรน-2ร‚รท

์ €ํ’ˆ์งˆ๋‚ฑ์žฅ.pdf

Overview -ingredient - mechanism 2. Biomarker 3. In vitro study 4. In vivo study 5. Human study 6. ๊ธฐ๋Šฅ์„ฑ ์ธ์ •์„œ 7.๊ธฐ์ค€๊ทœ๊ฒฉ ์ธ์ •์„œ

์ œ3์žฅ.ppt

Microsoft Word docx

์—ด๋ฆฐํฌํ•ญ 12์›”ํ˜ธ

๋ ˆ์ด์•„์›ƒ 1

0118_Wealth Management

ร€ยฑรˆยฐรƒรŸยฐรจยฝร‰ร†รทร†รŠร‡รƒยทยฟ 59รˆยธ-รƒร–รยพ

untitled

ยฟร€ยธยฎร„รž38

๋Œ€ํ‘œ์ด์‚ฌ ๋“ฑ ํ™•์ธ์„œ I. ํšŒ์‚ฌ์˜ ๊ฐœ์š” 1. ํšŒ์‚ฌ์˜ ๊ฐœ์š” ๊ฐ€. ํšŒ์‚ฌ์˜ ๋ฒ•์  ์ƒ์—…์  ๋ช…์นญ ๋‹น์‚ฌ์˜ ๋ช…์นญ์€ ๋Œ€์ƒํ™€๋”ฉ์Šค์ฃผ์‹ํšŒ์‚ฌ ๋ผ๊ณ  ํ‘œ๊ธฐํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ์˜๋ฌธ์œผ๋กœ๋Š” DAESANG HOLDINGS CO., LTD ๋ผ ํ‘œ๊ธฐํ•ฉ๋‹ˆ๋‹ค. ๋‹จ, ์•ฝ์‹์œผ๋กœ ํ‘œ๊ธฐํ•  ๊ฒฝ์šฐ์—๋Š” ๋Œ€์ƒํ™€๋”ฉ์Šค ๋˜๋Š” DAES

ยผ๏ฟฝยฐ๏ฟฝ341PDFยฟรซ

์€ํ‡ด์„ค๊ณ„1129(์•ž4๋„16p)

<30342DB1E2C8B9C6AFC1FD2028C0CCBAC0C1F D35392E687770>


๋‹ค์ด์–ดํŠธ๋งˆ์นจํ‘œ_1๋ถ€ :24 PM ํŽ˜์ด์ง€2 BMI์ง€์ˆ˜์˜ ์ง„์‹ค ๋น„๋งŒ์„ ์ธก์ •ํ•˜๋Š” ๋Œ€ํ‘œ์ ์ธ ๋ฐฉ๋ฒ• ๊ฐ€์šด๋ฐ ํ•˜๋‚˜๊ฐ€ BMI ์ง€์ˆ˜๋‹ค. BMI(Body Mass Index, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜)๋ž€ ํ‚ค์™€ ๋ชธ๋ฌด๊ฒŒ๋ฅผ ์ด์šฉํ•˜์—ฌ ์ง€๋ฐฉ์˜ ์–‘์„ ์ถ”์ •ํ•˜๋Š” ๋น„๋งŒ ์ธก์ •๋ฒ•์ด๋‹ค. ๋ชธ๋ฌด๊ฒŒ๋ฅผ ํ‚ค์˜

14๋…„5, 6์›” ํ•œ๋งˆ์Œ

Focus2รˆยฃpdf

<3034C0D3BBF3C3E1B0E8C7D0BCFABCBCB9CCB3AA2E687770>

์„ธ๊ณ„ํ‘œ์ค€๊ณผ ๋™๋–จ์–ด์ง„ ๋‚ก์€ ์กฑ์‡„๊ฐ€ ๋งˆ์นจ๋‚ด ํ’€๋ ธ์Šต๋‹ˆ๋‹ค. ์•ˆ๋…•ํ•˜์‹ญ๋‹ˆ๊นŒ? ๋Œ€ํ†ต๋ น์‹ค ๊ตญ์ •๊ธฐํš์ˆ˜์„๋น„์„œ๊ด€ ๋ฐ•์žฌ์™„์ž…๋‹ˆ๋‹ค. ๋ฐฉ์†ก๋ฒ•, ์‹ ๋ฌธ๋ฒ•, ์ธํ„ฐ๋„ท๋ฉ€ํ‹ฐ๋ฏธ๋””์–ด๋ฐฉ์†ก์‚ฌ์—…๋ฒ•(IPTV๋ฒ•) ๋“ฑ ์ด๋ฅธ๋ฐ” ๋ฏธ๋””์–ด์‚ฐ์—…๋ฐœ์ „๋ฒ• ๊ฐœ์ •์•ˆ์ด 7์›” 22์ผ ๊ตญํšŒ๋ฅผ ํ†ต๊ณผํ–ˆ์Šต๋‹ˆ๋‹ค. ์ด๋กœ์จ 1980๋…„๋Œ€ ๊ตฐ์‚ฌ์ •๊ถŒ์˜ ์–ธ๋ก ํ†ต

ฮณ

์‚ฌํšŒ๋™ํ–ฅ1-2์žฅ

ํ•™๊ตํญ๋ ฅํ‘œ์ง€

ํ˜„์žฌ๋„ ํ”ผ์šด๋‹ค. (a) Half pack a day (b) half to one pack a day ๋ฐ˜ ๊ฐ‘ ๋ฏธ๋งŒ ๋ฐ˜ ๊ฐ‘ ~ ํ•œ ๊ฐ‘ (c) one to two packs a day (d) more than 2 packs a day ํ•œ ๊ฐ‘ ~ ๋‘ ๊ฐ‘ ๋‘ ๊ฐ‘ ์ด์ƒ 5. Ho

๋ฏฟ์Œ, ์‹ ๋ขฐ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ๋‹น์‹ ์˜ ํ–‰๋ณตํ•œ ์ˆœ๊ฐ„์„ ์•ฝ์†ํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค ์ƒˆ๋กœ์šด ํ–‰๋ณต, ์„ค๋ ˆ๋Š” ์ถœ๋ฐœ์„ ์„ ์‚ฌํ•˜๊ธฐ ์œ„ํ•ด ์ตœ์„ ์„ ๋‹คํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค. ๊ฒฐํ˜ผ์ •๋ณดํšŒ์‚ฌ ๋Œ€๋ช…์œ„๋“œ์›์€ 600๋งŒ ์‹ฑ๊ธ€์—๊ฒŒ 1๋“ฑ ๊ฒฐํ˜ผ์„ ์•ฝ์†ํ•˜๊ฒ ์Šต๋‹ˆ ๋‹ค. ๊ฐ€์กฑ์˜ ๊ฐ€์น˜๋ฅผ ์†Œ์ค‘ํžˆ ์—ฌ๊ธฐ๊ณ  ์‚ฌ๋žŒ์ด ์ค‘์‹ฌ์ธ ๋Œ€๋ช…๊ทธ๋ฃน์˜ ์‚ฌ๋ช…์— ๋”ฐ๋ผ ์†Œ์ค‘ํ•œ


์†”๋ฃจ์…˜-M3-0.indd

YEONGGWANG BEOPSEONGPO SALTED YELLOW CORVINA Exquisite taste, Interweaving of Water Wind Sunshine Salt And time By human

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

๋‘์‚ฐ์ค‘๊ณต์—…์ฃผ์‹ํšŒ์‚ฌ์™€ ๊ทธ ์ข…์†๊ธฐ์—… ๋ถ„ ๊ธฐ ์—ฐ ๊ฒฐ ์žฌ ๋ฌด ์ œ ํ‘œ ์— ๋Œ€ ํ•œ ๊ฒ€ ํ†  ๋ณด ๊ณ  ์„œ ์ œ 53 ๊ธฐ 3๋ถ„๊ธฐ 2015๋…„ 01์›” 01์ผ ๋ถ€ํ„ฐ 2015๋…„ 09์›” 30์ผ ๊นŒ์ง€ ์ œ 52 ๊ธฐ 3๋ถ„๊ธฐ 2014๋…„ 01์›” 01์ผ ๋ถ€ํ„ฐ 2014๋…„ 09์›” 30์ผ ๊นŒ์ง€ ํ•œ์˜ํšŒ๊ณ„๋ฒ•์ธ ์ „์ž๊ณต

์‚ฌ์šฐ๋””์˜ ์‹ํ’ˆ ์‹œ์žฅ๊ฐœ์š” - ์‚ฌ์šฐ๋”” ์‹๋ฃŒํ’ˆ ์‹œ์žฅ์€ 50์–ต๋ถˆ๋กœ ์ค‘๋™์ง€์—ญ์˜(ํ„ฐํ‚ค, ์ด์Šค๋ผ์—˜ ํฌํ•จ) 14%๋ฅผ ์  ์œ ํ•˜๊ณ  ์žˆ์Œ ์‚ฌ์šฐ๋””๋Š” 2004๋…„ ๊ธฐ์ค€ 1์ธ๋‹น ์‹ํ’ˆ์†Œ๋น„๊ทœ๋ชจ 545.8๋‹ฌ๋Ÿฌ, 1์ธ๋‹น ๋Œ€ํ˜•์†Œ๋งค์  ํŒ ๋งค๊ทœ๋ชจ 122.5๋‹ฌ๋Ÿฌ ์ˆ˜์ค€์ž„ ์‚ฌ์šฐ๋””๋Š” ์ธ๊ตฌ์ฆ๊ฐ€์œจ์ด ๋†’์•„(3.4% ๋‚ด์™ธ

์ฃผ์ œ๋ฐœํ‘œ ์‹ํ’ˆ์†Œ๋น„๊ตฌ์กฐ์˜๋ณ€ํ™”๊ฐ€๊ตญ๋ฏผ๊ฑด๊ฐ•์—๋ฏธ์น˜๋Š”์˜ํ–ฅ ์—ฐ๊ตฌ์ฑ…์ž„์ž๋งน์›์žฌ ( ์ž์—ฐ์ œ 2 ๋ถ„๊ณผ ) ๊ณต๋™์—ฐ๊ตฌ์žํ™ํฌ์˜ฅ ( ์ƒ๋ช…๋Œ€ํ•™๊ต๊ฒธ์ž„๊ต์ˆ˜ ) - 2 -

untitled

02 ๋‚˜ ํ•ด๊ฒฐ๋˜์ง€ ์•Š์•„ ๊ณ ์‹ฌํ•˜๋˜ ์ค‘ ๋ฏธ์ƒ๋ฌผ๋„ ์ƒ๋ช…์ฒด์ด๋ฏ€๋กœ ์•ฝ์œก๊ฐ•์‹ํ•˜๋Š” ๋™๋ฌผ์˜ ์„ธ ๊ณ„์™€ ๊ฐ™์ด ๊ฐœ๊ตฌ๋ฆฌ ๊ฐ™์€ ์•ฝ์ž์™€ ํ˜ธ๋ž‘์ด ๊ฐ™์€ ๊ฐ•์ž๊ฐ€ ์žˆ๋‹ค๋Š” ์ž์—ฐ์˜ ์„ญ๋ฆฌ๊ฐ€ ์ƒ๊ฐ๋‚ฌ ๋‹ค. ๊ทธ๋ ‡๋‹ค๋ฉด ํ˜ธ๋ž‘์ด ๊ฐ™์€ ๋ฏธ์ƒ๋ฌผ์ด ์–ด๋””์— ์žˆ์„๊นŒ? ๋ผ๋Š” ์˜๋ฌธ์— ๋‹ต์ด ๋‚˜์™”๋‹ค. ์‚ด๊ท ๋ ฅ์ด ๋งค์šฐ ๊ฐ•๋ ฅํ•œ ์˜ป๋‚˜๋ฌด์™€

untitled

๋†๋ฆผ์ˆ˜์‚ฐ์‹ํ’ˆ๋ถ€์žฅ๊ด€๊ท€ํ•˜ ์ด๋ณด๊ณ ์„œ๋ฅผ ํŒฅ์˜๋Œ€์‚ฌ์„ฑ์งˆํ™˜๊ฐœ์„ ๋ฐ๊ธฐ๋Šฅ์„ฑ๊ทœ๋ช… ์—๊ด€ํ•œ์—ฐ๊ตฌ์˜์ตœ์ข…๋ณด๊ณ ์„œ๋กœ์ œ์ถœ ํ•ฉ๋‹ˆ๋‹ค ๋…„ 2 ์›” 11 ์ผ - 1 -

๋‚ด์ง€-์ˆ˜์ •.indd

์‚ฌ ์—… ๋ณด ๊ณ  ์„œ (์ œ 23 ๊ธฐ) ์‚ฌ์—…์—ฐ๋„ 2013๋…„ 01์›” 01์ผ 2013๋…„ 12์›” 31์ผ ๋ถ€ํ„ฐ ๊นŒ์ง€ ๊ธˆ์œต์œ„์›ํšŒ ํ•œ๊ตญ๊ฑฐ๋ž˜์†Œ ๊ท€์ค‘ 2014๋…„ 3์›” 31์ผ ์ œ์ถœ๋Œ€์ƒ๋ฒ•์ธ ์œ ํ˜• : ๋ฉด์ œ์‚ฌ์œ ๋ฐœ์ƒ : ์ฃผ๊ถŒ์ƒ์žฅ๋ฒ•์ธ ํ•ด๋‹น์‚ฌํ•ญ ์—†์Œ ํšŒ ์‚ฌ ๋ช… : ์ผ€์ดํ‹ฐํ•˜์ดํ…”์ฃผ์‹ํšŒ์‚ฌ ๋Œ€ ํ‘œ ์ด ์‚ฌ :

๋Œ€ํ‘œ์ด์‚ฌ๋“ฑ์˜ ํ™•์ธใ†์„œ๋ช… ํ™• ์ธ ์„œ ์šฐ๋ฆฌ๋Š” ๋‹น์‚ฌ์˜ ๋Œ€ํ‘œ์ด์‚ฌ ๋ฐ ์‹ ๊ณ ์—…๋ฌด๋‹ด๋‹น์ด์‚ฌ๋กœ์„œ ์ด ์‚ฌ์—…๋ณด๊ณ ์„œ์˜ ๊ธฐ์žฌ๋‚ด์šฉ์— ๋Œ€ํ•ด ์ƒ๋‹นํ•œ ์ฃผ์˜๋ฅผ ๋‹คํ•˜์—ฌ ์ง์ ‘ ํ™•์ธใ†๊ฒ€ํ† ํ•œ ๊ฒฐ๊ณผ, ์ค‘์š”ํ•œ ๊ธฐ์žฌ์‚ฌํ•ญ์˜ ๊ธฐ์žฌ ๋˜๋Š” ํ‘œ์‹œ์˜ ๋ˆ„๋ฝ์ด๋‚˜ ํ—ˆ์œ„์˜ ๊ธฐ์žฌ ๋˜๋Š” ํ‘œ์‹œ๊ฐ€ ์—†๊ณ , ์ด ์‚ฌ ์—…๋ณด๊ณ ์„œ์— ํ‘œ์‹œ๋œ ๊ธฐ์žฌ ๋˜

12 CO N T E N T S

11 CO N T E N T S

2011 ๊ตญํ† ํ•ด์–‘๋ถ€ ์†Œ์…œ๋ฏธ๋””์–ด

( )

2013<C724><B9AC><ACBD><C601><C2E4><CC9C><C0AC><B840><C9D1>(<C6F9><C6A9>).pdf

ยฟยกร€รŒยฝยบ รƒร–รยพยฟรธยฐรญ

0904fc52801a55dd

0121์‚ฌํšŒ๋™ํ–ฅ1์žฅ

LG Business Insight 1395

6. ์Œ์—์„œ ์„ค๋ช…ํ•˜๋Š” ์ง€์—ญ์‚ฌํšŒ๋ณต์ง€ ํŠน์„ฑ์€? ์ง€์—ญ์‚ฌํšŒ๋ณต์ง€๋Š” ์ฃผ๋ฏผ์˜ ์ƒํ™œ๊ถŒ์—ญ์„ ๊ธฐ์ดˆ๋กœ ํ•˜์—ฌ ์ „๊ฐœ๋˜๋Š” ๊ฒƒ์ด. ์ƒํ™œ๊ถŒ์—ญ์€ ์ฃผ๋ฏผ ์ƒํ™œ์˜ ์žฅ์ด๋ฉด ์„œ ๋™์‹œ์— ์‚ฌํšŒ์ฐธ๊ฐ€์˜ ์žฅ์ด๋ฏ€๋กœ ์ด ํŠน์„ฑ์„ ๊ณ ๋ คํ•˜์—ฌ์•ผ ํ•œ. ์ฃผ๋ฏผ์˜ ๊ธฐ์ดˆ์ ์ธ ์ƒํ™œ๊ถŒ์—ญ์„ ๊ตฌ๋ถ„ํ•˜๋Š” ๊ธฐ์ค€์€ ์–‘ํ•˜๋ฉฐ, ๋ฌผ๋ฆฌ์  ์‹ฌ๋ฆฌ์  ๋‚ด์šฉ๊นŒ์ง€ ํŒŒ

์—ฌ๋ฆ„ํ˜ธ-๋‚ด์ง€์›๋ณธ

hwp

Global Market Report Global Market Report ์‰ฝ๊ฒŒํ’€์–ด์“ดํƒœ๊ตญ์˜๋ฃŒ๊ธฐ๊ธฐ ํ™”์žฅํ’ˆ๋“ฑ๋ก๋ฐ์ธ์ฆ์ ˆ์ฐจ ๋ฐฉ์ฝ•๋ฌด์—ญ๊ด€

์‚ฌํšŒ๋™ํ–ฅ1-2์žฅ

LG Business Insight 1298

ยตยตร…ยฅยธร ร†ยฎ1

vol 123 ์ŠคํŽ˜์…œ ํ…Œ๋งˆ ํ†ต 2+

์‚ฌํšŒ๋™ํ–ฅ-๋‚ด์ง€๊ฐ„์ง€์ˆ˜์ •

<C3D6C1BEBFCFBCBA2DBDC4C7B0C0AFC5EBC7D0C8B8C1F D31C8A3292E687770>

์„œ์šธ์˜ ๊ณ ๋ นํ™” ํ˜„ํ™ฉ๊ณผ ๋Œ€์‘๋ฐฉ์•ˆ ๊ทธ๋ฆผ1 ์„œ์šธ์‹œ ์—ฐ๋ น๋ณ„ ์ธ๊ตฌ ๋ฐ ์ธ๊ตฌ๋น„์œจ๊ณผ ๋…ธ์ธ๋ถ€์–‘๋น„์œจ ์ถ”์ด <์—ฐ๋ น๋ณ„ ์ธ๊ตฌ ๋ฐ ์ธ๊ตฌ๋น„์œจ ์ถ”์ด> <๋…ธ์ธ 1๋ช…์„ ๋ถ€์–‘ํ•˜๋Š” ์ƒ์‚ฐ์ธ๊ตฌ ์ถ”์ด> 8,047 (76.7%) 1,368 (13.0%) 1,083 (10.3%) 2012๋…„ 7,609 (75.7

Health Essay ์„ฑ๊ฒฝํ›ˆ ๋Œ€ํ‘œ์›์žฅ์˜ ์ฒ™์ถ” ๊ด€์ ˆ ์ „๋ฌธ์˜ ๊ณ ๋ฅด๋Š” ๋ฒ• ์ฒ™์ถ” ๊ด€์ ˆ ์งˆํ™˜, ์˜์‚ฌ๋ฅผ ์ž˜ ๋งŒ๋‚˜์•ผ ํ•ฉ๋‹ˆ๋‹ค ๊ธ€ ์„ฑ๊ฒฝํ›ˆ 21์„ธ๊ธฐ๋ณ‘์› ๋Œ€ํ‘œ์›์žฅ ์‚ฌ์ง„ ๋ฐฑ๊ธฐ๊ด‘(์ŠคํŠœ๋””์˜ค100) ํ™˜์ž์—๊ฒŒ ์ ๊ทน์ ์œผ๋กœ ๋งŽ์ด ์งˆ๋ฌธํ•˜๋Š” ์˜์‚ฌ๋ฅผ ๋งŒ๋‚˜์„ธ์š”. ์ตœ์†Œํ•œ ์„ฑ์˜ ์žˆ๋Š” ์˜์‚ฌ์ผ ๊ฒƒ์ž…๋‹ˆ๋‹ค. ๋‚˜์•„๊ฐ€

(ํ•œ๋งˆ์Œ)

๋“ค์–ด๊ฐ€๋ฉด์„œ ๋ณธ ์‹์ƒํ™œ๊ฐ€์ด๋“œ ๋Š” ์—ฌ๋Ÿฌ๋ถ„๊ป˜์„œ ๋ฐ›์œผ์‹  ์‹์ƒํ™œ ํ‰๊ฐ€์ง€์˜ ๋‚ด์šฉ์„ ์‰ฝ๊ฒŒ ์ดํ•ดํ•˜์‹ค ์ˆ˜ ์žˆ๋„๋ก ๊ตฌ์„ฑ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์‹์ƒํ™œ ํ‰๊ฐ€์ง€๋Š” ์‹ํ’ˆ์„ญ์ทจ์กฐ์‚ฌ์—์„œ ์‘๋‹ตํ•˜์‹  ๋‚ด์šฉ์„ ๊ธฐ๋ฐ˜์œผ๋กœ ๋ถ„์„ํ•˜์—ฌ ์ฒด์ค‘ํ‰๊ฐ€, ์—๋„ˆ์ง€ ์„ญ์ทจํ‰๊ฐ€, ์‹ํ’ˆ ์„ญ์ทจ ํ‰๊ฐ€, ์˜์–‘์†Œ ์„ญ์ทจ ํ‰๊ฐ€ ๋“ฑ์˜ ๋‚ด์šฉ์„ ํฌํ•จํ•˜๊ณ  ์žˆ์Šต

์šธ๋œจ๋ ˆ์•ผ ๋‚ด์ง€-์ˆ˜์ •

< BBE7C2FBC0BDBDC420C1A4B1E2C7D0BCFA20BDC9C6F7C1F6BEF65FC0E7B1B32E687770>

SGแ„‘แ…ณแ„…แ…ขแ†ซ-แ„’แ…กแ†ซแ„‚แ…กแ†ทแ„Œแ…ฅแ†ท แ„Œแ…ตแ„‚แ…ฉแ„‹แ…งแ†ผแ„‰แ…ฎแ„Œแ…ฅแ†ผ.QXP

์กด๊ฒฝํ•˜๋Š” ๋…์ž ์—ฌ๋Ÿฌ๋ถ„!! ์งˆ๋ณ‘์—์„œ ํ•ด๋ฐฉ์šด๋™(21์„ธ๊ธฐ 3 1์šด๋™)์— ๋™์ฐธํ•˜๋ฉด ๋ฐ•๊ทผํ˜œ ์ •๋ถ€ ์ž„๊ธฐ์ด๋‚ด ์˜๋ฃŒ๋ณดํ—˜ 1/3๋งŒ ๋‚ฉ๋ถ€ํ•ด๋„ ํ™˜์ž๋ถ„๋‹ด๊ธˆ ์—†๋Š” ๊ตญ๋ฏผํ–‰๋ณต์‹œ๋Œ€๋ฅผ ์ž์†์—๊ฒŒ ๋ฌผ๋ ค์ค€๋‹ค. Korea OECD ํšŒ์›๊ตญ ์ค‘ ํ™˜์ž์ฆ๊ฐ€์œจ ์˜๋ฃŒ์ฆ๊ฐ€์œจ ์•”๋ฐœ์ƒ์œจ ์•”์‚ฌ๋ง์œจ 40~50๋Œ€ ์‚ฌ๋ง์œจ ๋ถˆ์ž„์œจ

ๆญฏ140๊น€๊ด‘๋ฝ.PDF

02 ORGA ORGANIC MILK ORGA LIFE / 6 ๊ธ€.ํ•œ์ •ํ˜œ ์ž์œ ๊ธฐ๊ณ ๊ฐ€ ์‚ฌ์ง„.Tone Studio ์ผ๋Ÿฌ์ŠคํŠธ.๋ฐ•๊ฒฝ์—ฐ ์ œ์ฃผ์˜ ๋ง‘์€ ๋ฐ”๋žŒ๊ณผ ๋ฌผ, ํ–‡๋ณ•์„ ๊ณ ์Šค๋ž€ํžˆ ํ’ˆ์€ ์ž์—ฐ์˜ ์„ ๋ฌผ ์˜ฌ๊ฐ€ ์œ ๊ธฐ๋†์šฐ์œ  ์†Œ์˜ ๊ฑด๊ฐ•๊ณผ ์†Œ๊ฐ€ ๋จน๋Š” ๊ฒƒ์ด ์šฐ์œ ์˜ ์งˆ์„ ์ขŒ์šฐํ•ฉ๋‹ˆ๋‹ค. ๊ฐ€

Transcription:

. - 199 -

. 1. DB (IPC) 10938,,. KIPIRS, WIPS, KINIT I DB,,,,,,,,,,,,, IPC (A21, A23, A61, C12) 2450 2 1303.,, suplement food, health food, functional food, body control, biorhythm control, aging control immunity, obesity control, nutrition absorption, fatty acid accumulation, obesity, appetite, peroxylipid, cholesterol, anti- diabetes, tooth- decay, hematopoiesis DB PAJ, PAT OLIS, KIPIRS, WIPS, KINIT I, IBM IPC 4300, 3200, 988 2 2256, 1218, 692. - 201 -

23 2518, 1836, 4394 5469. 4-1. DB DB,,,,,,,,,,,,,, KIPIRS,,,, WIPS,,,, KINITI,,,,,,,,,,,,,,, KFRI DAILOG 2450 body control, biorhythm control, aging control immunity, obesity control, brain function, nutrition PAJ absorption, skin promotion, anti- allergy, immunity, PATOLIS 4300 cell division factor, fatty acid accumulation, obesity, intestinal disorder, appetite, brain funtion, improvement, nutrition, peroxylipid, blood pressure, cholesterol, arteriosclerosis, anti-thrombus, blood sugar, antidiabetes, anti-mutagen, anti-tumor, tooth- decay, KIPIRS 3200 WIPS preventation, hematopoiesis, blood plasma, liver, phenylketonuria, hormone, curculatory system control, blood sugar control, carcinogenesis control, indisposition metabolism, suplement food, health food, functional food KINITI DAILOG WPI IBM 988 and IPC (A61,A21,A23 C12) 10,938-202 -

4-2. (T ) 10,938 (A) 2,518 (B) 1,836, (C) 4,394 (F ) 5,469 * A, B, C ** F =A+B+C- 1-1. 1-1- 1. /,,, ( 4-3). - 203 -

4-3. /,,,, /,, / /,,,,,,,,,,,,,,,,,,,,, /,,,,,,,,,,,,, - 204 -

,,,,, /,,, /,,,,, /,,,,, /, /,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ( ),, /, /, / /, - 205 -

/ /,,,,,,,,,,,, /,,, /,,, /,,,,,,,,,,,,,,,,,,,,,,,,, /,,,,,,,,, - 206 -

1-1- 2.. 4-4 - 207 -

4-4. - 208 -

, Herb - 209 -

1-1- 3.,,, 4, 4-5. :, : :. : E - 210 -

4-5. / / / / - 211 -

2. 2-1. 1980. 1980,. 1984. 1999. 4-1. - 212 -

2-2. 10 (2,922)(1.9)26.. P&G Ajino moto Nestle sa Snow brand food Unilever nv Nabisco inc Aabbott lab Nestec ltd Warner - lambe rt co 113 55 53 46 45 38 36 35 29 29 29 508 113 55 53 46 45 38 36 35 29 29 29 508 4-2. 10-213 -

P&G T he Procter & Gamble 113 12 2. 2 Ajinomoto Snow brand food.,. 4-3. 7 2-3. 4 5469, 2256 41%. 1303, 1218, 69224%, 22%, 13%. - 214 -

4-4. 1984. 1994 10. 1988. 1989. 1994. - 215 -

1990 1994 1994.. 4-5. - 216 -

3. 3-1. 3-1- 1., 1982. 1989 20. 1999 2000. 4-6. - 217 -

3-1- 2. (2,436) 10 414 (1.8) 23.. P&G Nestle sa Ajino moto Unilever nv Snow brand food Nabisco inc Kraft Food Osaka chem lab 88 49 45 44 38 37 34 27 26 26 414 88 49 45 44 38 37 34 27 26 26 414 4-7. 10-218 -

4-8. 5 3-1- 3. 1/ 2. 1/ 2 1/ 4.,. - 219 -

4-9. 3-1- 4. 4-10. - 220 -

4394 225150%. 920 21% (: 728 ), (422 ) 17%, 10%. (6 ), (4 ), (3 ). 3-1- 4-1. 75. 64, 40. 910 1096 87%. 4-1 1. - 221 -

3-1- 4-2., 530 391 73%, 27%., 75, 56. 7. 7 ( ),,,. 4-12. - 222 -

3-1- 4-3. 7 60% 45%.,.. 4-13. - 223 -

3-2. 3-2 - 1.,,. 4-14.,,.. - 224 -

4-15. 3-2 - 2. (FOSHU). /,. 4-16. - 225 -

4-17. 8,. 3-2 - 3. NLEA (Nutrition Labeling and Education Act) DSHEA (Dietary Supplements Health and Education Act). NLEA DSHEA. - 226 -

4-18., P&G, Abbot Lab Staley. 4-19. - 227 -

3-2 - 4.,,. 4-2 0. P&G42 1, 3 31/ 6,. - 228 -

4-2 1. 3-3. 3-3 - 1. / 3-3 - 1-1. / /,,,,, 5 1.. /,,,. 1998-229 -

.,.,,,. 4-2 2. / / () 1980-230 -

,,,,. 1995,,. 4-2 3. /,,, - 231 -

.,,.. 1998 6., DHA.. / 1990.,,,. (, )., DHA. - 232 -

/ 28 ( ) 2 3 4 1. 5 1 1. 3-3 - 1-2. / /,,,,,. T aiyo fishery ltd., Ota toshiyuki, Ajinomoto, Fuji foods, Snow brand food, Kibun foods. /, 90%., 70%., (),. - 233 -

4-2 4. / (Kibun food), (T aiyo fishery), (Nippon suisan )/ 70%. 4-2 5. / - 234 -

...,. Mitubishi Kikkoman, (Fuji food). Mitubishi Kikkoman, (Fuji food). (),. 1994 1... - 235 -

, (Nippon oil), (Morinaga),,. 3-3 - 1-3. /,,. 5 Nestec ltd. Kraft Food.,,,,,. 40%., 1998. 800,000 Mt4 1 200 1994 1999 15%,.,. - 236 -

4-2 6. /,, P&G. 1997. 5,. Hormel Foods 1990gelatin, edible collagen proteins, meat & poultry powders1994. - 237 -

4-2 7. / ().,..,.,,. - 238 -

,. 3-3 - 1-4. / /.,. 1/ 3.,,,. 4-2 8. / - 239 -

(Milupa ). (Unilever). (Kraft),. 4-2 9. /,. - 240 -

,. 1991 ( ) 2-3.., (Unilever) (Best food). 3-3 - 2. 3-3 - 2-1..,,,.,,,,. - 241 -

4-3 0.,, ( ). 1990,. (Hayashibara Biochem - 242 -

lab.). Mitubishi 1996. P&G.. 3-3 - 2-2.,,,,,,. ( ), ( ),,.,,. - 243 -

4-3 1. ( ) ( ),,. (Fuji food), (Nippon oil).. (). 1996 1997. - 244 -

(Hayashibara Biochem lab.) 1981. 1991 (T rehalose). Mitubishi 1996. 3-3 - 2-3..,.,. 4-3 2. - 245 -

1970., 1994. /, (Snow brand food), (Kao). P&G 3-3 - 2-4.,.,. - 246 -

4-3 3. /, P&G,. /. 1990. / 1980-247 -

. 1998. P&G,. 3-3 - 3. 3-3 - 3-1..,,,. 1997. 4-3 4. - 248 -

,. ( ). 3-3 - 3-2. 1995. 100% /,,... 4-3 5. - 249 -

1990 / 1980.. 3-3 - 3-3.,.. 4-3 6. - 250 -

Lipton, Nestec. P&G ( ). 3-3 - 3-4... 4-3 7. - 251 -

P&G General Food. 3-3 - 4. 3-3 - 4-1. 19992 -,,. 1997 3.,, 1990. 4-3 8. - 252 -

P&G, W arner- lambert 1997.. 4-3 9. 3-3 - 4-2.,,, 1991,,.. - 253 -

4-4 0. (Kanebo), (Ajinomoto), (Asahi beer ), (Osaka Chem ) 1982. 3-3 - 4-3.,. - 254 -

4-4 1., P&G,. 3-3 - 4-4. 70%.,.. - 255 -

4-4 2.. P&G, W arner - lambert. 3-3 - 5. /,. - 256 -

3-3 - 5-1.. 1987. 1989,,,,,,. 1990 21. 1991, 1993, 1996., 1995 2. 19981997.. - 257 -

4-4 3.,, 4-4 4. - 258 -

3-3 - 5-2. 1978 13 1988 13, 1991 11, 1998 10 47... 4-4 5.,,, T erumo corp.,, - 259 -

. 3-3 - 5-3. 1990 1994 (DSHEA ).,,,,,,. 300. 1994. 4-4 6. - 260 -

P&G, (Abbot Lab),. 3-3 - 5-4. ( ),,,,.. 4-4 7. - 261 -